Dutasteride, Finasteride: No Increased Risk of Erectile Dysfunction

    October 2016 in “ Reactions Weekly ”
    Image of study
    TLDR Dutasteride and finasteride don't raise erectile dysfunction risk.
    A UK study published in the BMJ found that treatment with 5-α reductase inhibitors for alopecia or benign prostatic hyperplasia (BPH) does not increase the risk of erectile dysfunction (ED). The study used data from the UK Clinical Practice Research Datalink and evaluated the risk of ED in 71,849 men ≥40 years of age with BPH receiving 5-a reductase inhibitors (dutasteride or finasteride) alone, or 5-a reductase inhibitors + α-blockers, or a-blockers alone; and in 12,346 men 18-59 years of age with alopecia receiving finasteride or no treatment. The study concluded that 5-a reductase inhibitors do not increase the risk of clinically meaningful incident erectile dysfunction or non-erectile dysfunction sexual dysfunction in men who are free of sexual dysfunction and major risk factors.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 1000+ results

      community 1 month of using fin, so happy

      in Progress Pictures  865 upvotes 4 months ago
      User had a hair transplant and used a finasteride and minoxidil spray for 6 months with no results. After adding finasteride tablets for 1 month, they saw significant hair growth improvement.
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 4 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community Hair Loss Drugs Ranked in Order of Efficacy

      in Research/Science  67 upvotes 1 year ago
      Dutasteride is likely the most effective treatment for male pattern baldness, followed by finasteride and minoxidil in various forms and dosages. Users discuss personal experiences, dosages, and potential side effects, with some considering combining treatments for better results.

      community Massive study on finasteride side effects released

      in Finasteride/Dutasteride  83 upvotes 1 year ago
      The release of a study on 5a-reductase inhibitors (finasteride and dutasteride) which showed an increased risk of depression, dementia, decreased libido, and reduced semen load as potential side effects; discussion around other forms of hair loss treatments such as topical minoxidil, RU58841, or opting to accept baldness; and advice to consider professional help for deeper issues related to hair loss.

    Related Research

    2 / 2 results